To include your compound in the COVID-19 Resource Center, submit it here.

Prevnar 13 meets endpoints in adults over 50

Pfizer Inc. (NYSE:PFE) said Prevnar 13 met the primary endpoints in two Phase III trials

Read the full 152 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE